13 participants
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-18
- Start Date:
- 2020-07-02
- Completion:
- 2021-10-07
Conditions
- Advanced Solid Tumor
- B Cell Lymphoma
Interventions
- DRUG
No Results Yet